CNIO team turns tumor suppressor into anti-cancer target

December 4, 2013
This shows skulls from normal mice and from mice with a Cdh1 deficiency, whose cranial capacity has increased due to hydrocephalus. Credit: CNIO

The laboratory of Marcos Malumbres, who is head of the Spanish National Cancer Research Centre's (CNIO) Cell Division & Cancer Group, working alongside Isabel Fariñas' team from the University of Valencia, shows, in a study published today in the journal Nature Communications, how in mice the elimination of the Cdh1 protein —a sub-unit of the APC/C complex, involved in the control of cell division—prevents cellular proliferation of rapidly dividing cells. These results could accelerate the development of new therapies targeting cancer.

Malumbres's group had previously discovered that the inactivation of another APC/C protein, Cdc20, prevented . These results caught the attention of pharmaceutical companies, who are already developing the first inhibitors from the complex. These molecules have caused controversy due to the possible side effects of blocking Cdh1, which is considered a tumour suppressor.

Manuel Eguren has analysed the biological consequences of Cdh1 elimination in rapidly dividing cells, as part of his doctoral research project in Malumbres's group; he focused on progenitors from the nervous system during embryonic development in mice.

Via a detailed biochemical and cell study, researchers have discovered that the absence of Cdh1 causes DNA damage in cells. This defect causes cell death and leads to alterations in the development of the nervous system such as hydrocephalus, characterised by abnormal accumulation of fluid on the brain.

"Our results solve the controversy about the possible side effects of APC/C inhibitors", says Malumbres, adding that: "we have shown in vivo that their elimination leads to the death of rapidly dividing cells".

Implications for tumour treatment

The study is now focused on proposing a precise strategy for specific tumour types. "It could work in glioblastomas given that our study is based on brain progenitors, but we believe it could be extended to include other tumour types", say the researchers.

The CNIO researchers show that cell defects caused by the inhibition of Cdh1 are independent of the presence of the p53 molecule, which is mutated in different types of tumours. "The therapeutic effect of inhibiting Cdh1 should even work in tumours that carry mutations in this molecule", says Malumbres.

Explore further: CNIO researchers propose a new therapeutic target that prevents cell division

More information: The APC/C cofactor Cdh1 prevents replicative stress and p53-dependent cell death in neural progenitors. Manuel Eguren, Eva Porlan, Eusebio Manchado, Irene García-Higuera, Marta Canñamero, Isabel Fariñas, Marcos Malumbres. Nature Communications (2013). DOI: 10.1038/ncomms3880

Related Stories

CNIO researchers propose a new therapeutic target that prevents cell division

October 8, 2013
Cell division is an essential process for the development of an organism. This process, however, can cause tumour growth when it stops working properly. Tumour cells accumulate alterations in their genetic material, and this ...

Study validates new anti-cancer therapy based on cell division

November 18, 2013
Aurora-A is a protein involved in the cell division process that is highly expressed or synthesised in a large number of human cancers, especially in those associated with a bad prognosis. Several pharmaceutical companies ...

Potential brain tumour drug can distinguish cancer cells from healthy ones

October 31, 2013
A potential new drug, already in clinical development, can stop brain tumour cells growing while leaving healthy cells alone, according to new research published today (Wednesday) in PLOS ONE.

Chemotherapy and herpes can help fight cancer, study finds

November 20, 2013
(Medical Xpress)—Combining chemotherapy with a herpes virus has shown promise in killing cancer cells and tumours during initial testing, two complementary McMaster studies have found.

Scientists find the "missing link" in important tumour suppression mechanism

November 12, 2013
Novel discovery relating to the function of RUNX3 gene provides new insights on human defence mechanism against early stages of lung cancer development

Recommended for you

Cancer-death button gets jammed by gut bacterium

July 27, 2017
Researchers at Michigan Medicine and in China showed that a type of bacterium is associated with the recurrence of colorectal cancer and poor outcomes. They found that Fusobacterium nucleatum in the gut can stop chemotherapy ...

Researchers release first draft of a genome-wide cancer 'dependency map'

July 27, 2017
In one of the largest efforts to build a comprehensive catalog of genetic vulnerabilities in cancer, researchers from the Broad Institute of MIT and Harvard and Dana-Farber Cancer Institute have identified more than 760 genes ...

Long-sought mechanism of metastasis is discovered in pancreatic cancer

July 27, 2017
Cells, just like people, have memories. They retain molecular markers that at the beginning of their existence helped guide their development. Cells that become cancerous may be making use of these early memories to power ...

Manmade peptides reduce breast cancer's spread

July 27, 2017
Manmade peptides that directly disrupt the inner workings of a gene known to support cancer's spread significantly reduce metastasis in a mouse model of breast cancer, scientists say.

Blocking the back-door that cancer cells use to escape death by radiotherapy

July 27, 2017
A natural healing mechanism of the body may be reducing the efficiency of radiotherapy in breast cancer patients, according to a new study.

Glowing tumor technology helps surgeons remove hidden cancer cells

July 27, 2017
Surgeons were able to identify and remove a greater number of cancerous nodules from lung cancer patients when combining intraoperative molecular imaging (IMI) - through the use of a contrast agent that makes tumor cells ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.